Boston Scientific Aktie News

With their robustness and growth potential, healthcare stocks are becoming a focal point in portfolios worldwide. Moreover, the U.S. stands out at the forefront of healthcare spending, allocating a staggering $4.3 trillion annually.

Ozempic could make some medical devices less necessary than before. If that happens, it would lead to lower revenue for the device makers.

The U.S. continues to spend more money on healthcare than any other country. Healthcare spending totaled $4.3 trillion, according to the American Medical Association.

Recent healthcare plan coverage of Intracept® system expands access to vertebrogenic pain treatment for tens of millions of patients MARLBOROUGH, Mass. , Nov. 17, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept® Intraosseous...

Eccogene out-licenses global rights for its GLP-1 agonist to AstraZeneca in a $2 billion deal. Biotheus sells ex-China rights for a bispecific antibody candidate to BioNTech for $55 million upfront. WuXi XDC conducts a $500 million Hong Kong IPO to expand its manufacturing capacity for ADCs and bioconjugates.

The company reported revenue of $3.5 billion and adjusted earnings of $0.50 per share, compared to the consensus estimates of $3.4 billion and $0.48, respectively.

MARLBOROUGH, Mass. , Nov. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Stifel's 2023 Healthcare Conference on Tuesday, November 14, 2023.

Boston Scientific narrowly beat third-quarter expectations and raised its 2023 outlook on Thursday, leading BSX stock to rise.